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Abstract
Given the absence of effective population-based screening tests for ovarian, uterine, vaginal, and 
vulvar cancers, early detection can depend on women and health care providers recognizing the 
potential significance of symptoms. In 2008, the Centers for Disease Control and Prevention’s 
(CDC) Inside Knowledge campaign began distributing consumer education materials promoting 
awareness of gynecologic cancer symptoms. We investigated providers’ in-office use of CDC 
gynecologic cancer materials and their recognition of the symptoms highlighted in the materials. 
We analyzed data from a national 2012 survey of US primary care physicians, nurse practitioners, 
and gynecologists (N = 1,380). Less than a quarter of providers (19.4 %) reported using CDC 
gynecologic cancer education materials in their offices. The provider characteristics associated 
with the use of CDC materials were not consistent across specialties. However, recognition of 
symptoms associated with gynecologic cancers was consistently higher among providers who 
reported using CDC materials. The possibility that providers were educated about gynecologic 
cancer symptoms through the dissemination of materials intended for their patients is intriguing 
and warrants further investigation. Distributing consumer education materials in health care 
provider offices remains a priority for the Inside Knowledge campaign, as the setting where 
women and health care providers interact is one of the most crucial venues to promote awareness 
of gynecologic cancer symptoms.
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Introduction
Increasing gynecologic cancer awareness became a national health priority on January 12, 
2007 when the Gynecologic Cancer Education and Awareness Act of 2005, or Johanna’s 
Law [1], was signed into law by the 109th US Congress. The legislation authorized the 
Centers for Disease Control and Prevention (CDC), in collaboration with the US Department 
of Health and Human Services’ Office on Women’s Health, to develop a campaign to raise 
awareness among women and health care providers about the signs, symptoms, risk factors, 
and prevention strategies related to gynecologic cancers. CDC then began developing Inside 
Knowledge: Get the Facts About Gynecologic Cancer (www.cdc.gov/cancer/knowledge), a 
national multi-media campaign to raise awareness about the five leading gynecologic 
cancers—cervical, ovarian, uterine, vaginal, and vulvar.
Given the lack of effective population-based screening tests for gynecologic cancers other 
than cervical cancer (the Papanicolaou or Pap test), educating women and health care 
providers about potentially significant symptoms remains a critical strategy to increase early 
detection [2–6]. Inside Knowledge promotes awareness of specific symptoms associated 
with gynecologic cancers, as well as risk factors and disease prevention strategies.
In 2008, the campaign began developing consumer education materials, guided by formative 
and materials testing research with women and health care providers [7–11]. The campaign 
and its materials have been promoted in the mainstream media including television, radio, 
and Internet advertisements, as well as at medical conferences and in peer-reviewed 
publications [7–14]. More than 1.4 million copies of materials had been ordered or 
downloaded from the campaign’s web site as of April 2013.
To inform provider outreach efforts, CDC’s Inside Knowledge campaign investigated the 
characteristics of US primary care physicians, nurse practitioners, and gynecologists 
associated with the in-office use of CDC gynecologic cancer education materials and 
provider recognition of the symptoms that are highlighted in the materials.
Methods
DocStyles is an annual, Internet-based survey that investigates the attitudes and clinical 
practices of US health professionals. The 2012 DocStyles survey was administered by Porter 
Novelli (Washington, D.C.) in July. A variety of provider groups took part, but the analyses 
reported here were limited to primary care physicians, nurse practitioners, and 
gynecologists.
Participants
Physicians and nurse practitioners who participated in the 2012 DocStyles survey included 
those who practiced in the USA, actively saw patients, and had practiced for at least 3 years. 
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The physician sample was randomly selected from the Epocrates Honors Panel®, which 
included 275,000 medical practitioners, to match the American Medical Association’s 
(AMA) Masterfile® proportions for age, gender, and region. The identities of panel 
members were verified by checking each physician’s first name, last name, date of birth, 
medical school, and graduation date against the AMA Masterfile at the time of panel 
registration. The nurse practitioner sample was drawn from Epocrates’ Allied Health Panel® 
of over one million health professionals, including 78,668 nurse practitioners; the identities 
of nurse practitioners were not verified.
Quota sampling involves deliberately setting the proportions of selected participant 
characteristics within a sample [15] and was incorporated into the 2012 DocStyles survey 
methods to ensure adequate representation of all provider groups surveyed. Sampling quotas 
were set at 1,000 primary care physicians (internists and family practitioners), 250 nurse 
practitioners, and 250 gynecologists. Email invitations to participate in the survey were sent 
to 2,175 primary care physicians, 456 nurse practitioners, and 489 gynecologists. Per 
sampling quotas, completed surveys were accepted from 1,001 primary care physicians, 252 
nurse practitioners, and 250 gynecologists. In addition, providers who did not treat adult 
female patients and those who worked primarily in inpatient care settings were excluded 
from the analyses, which narrowed the sample to 892 primary care physicians, 240 nurse 
practitioners, and 248 gynecologists, (N = 1,380). To protect confidentiality, no individual 
identifiers were included in the dataset provided to investigators, and the analyses reported 
here were exempted from CDC Institutional Review Board approval.
Measures
Participants were asked to indicate where gynecologic cancer education materials were 
available in their offices. Responses included (1) patient waiting area, (2) examination room, 
(3) other location in my office, and (4) this material is not available in my office. Multiple 
responses were accepted unless “this material is not available in my office” was selected.
Participants who reported using gynecologic cancer education materials in their offices were 
asked what organization produced the materials. Responses included (1) American Cancer 
Society (ACS), (2) American Congress of Obstetricians and Gynecologists (ACOG), (3) 
Centers for Disease Control and Prevention (CDC), (4) Facts for Women: Reproductive 
Cancer Awareness campaign, (5) Inside Knowledge: Get the Facts About Gynecologic 
Cancer campaign, (6) National Cancer Institute, (7) Society of Gynecologic Oncologists, (8) 
WebMD, (9) other, and (10) not sure. Multiple responses were accepted unless “not sure” 
was selected.
Providers were also provided a list of symptoms highlighted in CDC gynecologic cancer 
education materials (Table 1) and asked which cancers they associated with each symptom. 
Responses included (1) cervical cancer, (2) ovarian cancer, (3) uterine cancer, (4) vaginal 
cancer, (5) vulvar cancer, and (6) none of these. Multiple responses were accepted unless 
“none of these” was selected.
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Within each provider group, descriptive statistics were used to examine and summarize 
participant characteristics and use of gynecologic cancer education materials. Next, Pearson 
chi-square and t tests were performed to investigate the associations between provider 
characteristics (gender, race, practice size, geographic region of practice location, and 
number of Pap tests performed monthly) and use of CDC gynecologic cancer education 
materials.
Pearson chi-square tests were used to compare the recognition of the symptoms highlighted 
in CDC gynecologic cancer education materials between providers who used CDC 
gynecologic cancer education materials and providers who did not (providers who used non-




Most participants were male (60.1 %), white (77.8 %), and practiced in settings with 2–9 
other practitioners (54.1 %) (results not shown). Participants were relatively evenly 
distributed by geographic region: Northeastern states (27.0 %), Southern states (22.5 %), 
Western states (23.6 %), and Midwestern states (27.0 %). The mean number of Pap tests 
performed during a typical month varied by specialty: primary care physicians (13.7 tests), 
nurse practitioners (24.6 tests), and gynecologists (119.1 tests).
Use of Gynecologic Cancer Education Materials
Among gynecologists, reported in-office use of gynecologic cancer education materials was 
almost universal (96.0%), and the majority of primary care physicians (73.4 %) and nurse 
practitioners (71.1 %) also reported the use of such materials (results not shown). More than 
half of the participants across provider groups reported that gynecologic cancer education 
materials were available in their patient waiting rooms (55.6%) and examination rooms 
(54.4%). The most common sources of gynecologic cancer education materials were ACOG 
(33.7 %), ACS (32.0 %), and CDC (18.1 %). Less than a quarter of providers (19.4 %) 
reported using materials developed by CDC or the Inside Knowledge campaign. In the 
remaining analyses, participants were classified as using materials produced by CDC if they 
reported using materials produced by CDC or the Inside Knowledge campaign.
Primary care physicians practicing in Northeastern states were less likely to report using 
CDC materials (11.0 %) compared with those practicing in other regions (18.8–19.6 %) 
(χ2=8.62, p = 0.035). Among primary care physicians, the use of CDC materials was 
associated with higher Pap test volume: mean monthly Pap tests was 18.8 tests among those 
who used CDC materials and 12.7 tests among those who did not use CDC materials (t = 
3.79, p <0.001).White primary care physicians and nurse practitioners were less likely to 
report use of CDC materials than practitioners of other races: 15.1 % of white primary care 
physicians compared with 21.8 % of primary care physicians of other races (χ2=5.66, p = 
0.017), and 24.2 % of white nurse practitioners compared with 52.9 % of nurse practitioners 
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of other races (χ2=6.73, p = 0.009). No significant predictors of using CDC gynecologic 
cancer education materials were detected among gynecologists.
Recognition of Gynecologic Cancer Symptoms Highlighted in CDC Materials
Recognition of gynecologic cancer symptoms was generally higher among gynecologists 
than among primary care physicians and nurse practitioners (Table 1). Across provider 
groups, low recognition (<25 %) of at least one symptom of the cancers studied was found 
with the exception of uterine cancer—the majority in all provider groups recognized all of 
the uterine cancer symptoms studied. Symptom recognition was consistently higher among 
providers who reported using CDC gynecologic cancer education materials compared with 
other providers. When symptom recognition was analyzed in aggregate (all provider groups 
combined), providers who reported use of CDC materials were significantly more likely to 
recognize 11 of the 21 gynecologic cancer symptoms studied than providers who did not use 
CDC materials.
Discussion
Reported use of CDC gynecologic cancer education materials was consistent with the large 
number of materials distributed by the Inside Knowledge campaign to date. Provider 
familiarity with the symptoms associated with gynecologic cancers varied widely, but those 
who reported in-office use of CDC gynecologic cancer education materials consistently 
exhibited higher symptom recognition. Given the cross-sectional design of this study, it is 
not possible to determine the extent to which providers gained knowledge from CDC 
materials or more knowledgeable providers selected CDC materials for use in their offices. 
The possibility of educating providers through the dissemination of materials intended for 
their patients is certainly intriguing and warrants further investigation.
Awareness of symptoms that can signal gynecologic cancer is low among US women [4, 8], 
and more education is needed. At the same time, care must be taken to emphasize that some 
symptoms known to be signs of gynecologic cancers can also be caused by many benign 
conditions. Disseminating consumer education materials that strike this delicate balance 
remains a priority for CDC’s Inside Knowledge campaign. Routine examinations and visits 
for Pap tests offer opportunities for providers to counsel women about the symptoms that 
may be associated with gynecologic cancer—particularly, postmenopausal bleeding, which 
should trigger immediate consultation with a health care provider. In the absence of 
recommended population-based screening tests for ovarian, uterine, vaginal, and vulvar 
cancers, detection can depend largely on women informing providers that they are 
experiencing a symptom and providers investigating the underlying cause.
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